Health
Study reports highly potent anti-SARS-CoV-2 compounds – News-Medical.Net
A new study published on the preprint server bioRxiv in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary …
A new study published on the preprint server bioRxiv* in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary viral proteases. The authors urge rapid clinical and preclinical testing of their most potent compounds to meet the need for an effective antiviral therapeutics for the ongoing pandemic of COVID-19.
Introduction to the Viral Polyprotein Pr…
-
Noosa News19 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Business24 hours agoWhere will Nvidia stock be in 1 year?
-
General24 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts